56 results on '"Siersema, P"'
Search Results
2. Impact of prediagnostic smoking and smoking cessation on colorectal cancer prognosis: a meta-analysis of individual patient data from cohorts within the CHANCES consortium
3. Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease
4. The Economic Impact of the Introduction of Biosimilars in Inflammatory Bowel Disease
5. P726 High mortality risk after first hospital admission for inflammatory bowel disease: a nationwide registry linkage study
6. P722 Prediagnostic serum vitamin D levels and risk of inflammatory bowel disease: a pan-European, nested case-control study
7. Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease
8. Assessment of bolus transit with intraluminal impedance measurement in patients with esophageal motility disorders
9. Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease – interim results of an international multicentre trial
10. Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study
11. Surveillance in patients with long-segment Barrettʼs oesophagus: a cost-effectiveness analysis
12. Asociación entre el estatus socioeconómico, tratamiento quirúrgico y mortalidad en pacientes con cáncer colorrectal
13. Association between socioeconomic status, surgical treatment and mortality in patients with colorectal cancer
14. Upregulation of miRNA-143, -145, -192, and -194 in esophageal epithelial cells upon acidic bile salt stimulation
15. Sensation of stasis is poorly correlated with impaired esophageal bolus transport
16. Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease
17. Normal values for esophageal high-resolution manometry
18. HEMOCHROMATOSIS GENE (HFE) MUTATIONS AND THE RISK OF GASTRIC CANCER IN THE EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION STUDY: O023
19. Esophageal motor responses to increasing adjustment of an implanted gastric band
20. Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans
21. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia
22. Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European prospective investigation into cancer and nutrition
23. Admission time is associated with outcome of upper gastrointestinal bleeding: results of a multicentre prospective cohort study
24. Squamous cell carcinoma in Barrettʼs esophagus: field effect versus metastasis
25. Relationship between esophageal contraction patterns and clearance of swallowed liquid and solid boluses in healthy controls and patients with dysphagia
26. Duodenal lipid-induced symptom generation in gastroesophageal reflux disease: role of apolipoprotein A-IV and cholecystokinin
27. Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients
28. Reproducibility of esophageal high-resolution manometry
29. Disease burden of post-infectious irritable bowel syndrome in The Netherlands
30. Expression of p53 as predictor for the development of esophageal cancer in achalasia patients
31. Systematic review: the role of self-expanding plastic stents for benign oesophageal strictures
32. Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease
33. Socio-demographic factors influence chronic proton pump inhibitor use by a large population in the Netherlands
34. Radiologist experience and CT examination quality determine metastasis detection in patients with esophageal or gastric cardia cancer
35. Gastro-oesophageal reflux, medical resource utilization and upper gastrointestinal endoscopy in patients at risk of oesophageal adenocarcinoma
36. Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts
37. Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage
38. Environmental risk factors in the development of adenocarcinoma of the oesophagus or gastric cardia: a cross-sectional study in a Dutch cohort
39. Grading of dysplasia in Barrettʼs oesophagus: substantial interobserver variation between general and gastrointestinal pathologists
40. Down syndrome and esophageal cancer
41. Does CDX2 expression predict Barrettʼs metaplasia in oesophageal columnar epithelium without goblet cells?
42. Experiences and expectations of patients after oesophageal cancer surgery: an explorative study
43. Persistence and adherence to proton pump inhibitors in daily clinical practice
44. Oesophagitis is common in patients with achalasia after pneumatic dilatation
45. Increasing incidence of Barrett’s oesophagus in the general population
46. MUC4 is increased in high grade intraepithelial neoplasia in Barrett’s oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio
47. Oesophageal Cancer Incidence and Mortality in Patients with Long-Segment Barrettʼs Oesophagus After a Mean Follow-Up of 12.7 Years
48. The homeodomain protein CDX2 is an early marker of Barrett’s oesophagus
49. 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial
50. Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.